Skip to content

Clinical trials

Phase 2 Atrial Fibrillation trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 2 Country / region: Canada Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20064
20071
20081
20101
20112
20143
20161
20171
20191
20202
20212
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting3
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hamilton Health Sciences Corporation3
GlaxoSmithKline2
ARCA Biopharma, Inc.1
ARYx Therapeutics1
Advanz Pharma1
Annetine Gelijns1
Anthos Therapeutics, Inc.1
Bayer1
Bristol-Myers Squibb1
C. R. Bard1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation27
Venous Thromboembolism4
Atrial Flutter3
Stroke3
Heart Failure2
Heart Valve Diseases2
Hemorrhage2
Thromboembolism2
Venous Thrombosis2
Arrhythmias, Cardiac1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.